231 related articles for article (PubMed ID: 7867564)
1. Ligand requirements of the human corticotropin-releasing factor-binding protein.
Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
[TBL] [Abstract][Full Text] [Related]
4. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
5. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
[TBL] [Abstract][Full Text] [Related]
7. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
8. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay.
Behan DP; Khongsaly O; Liu XJ; Ling N; Goland R; Nasman B; Olsson T; De Souza EB
J Clin Endocrinol Metab; 1996 Jul; 81(7):2579-86. PubMed ID: 8675581
[TBL] [Abstract][Full Text] [Related]
9. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free' CRF levels in human brain.
Behan DP; Khongsaly O; Ling N; De Souza EB
Brain Res; 1996 Jul; 725(2):263-7. PubMed ID: 8836534
[TBL] [Abstract][Full Text] [Related]
10. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
11. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.
Gulyas J; Rivier C; Perrin M; Koerber SC; Sutton S; Corrigan A; Lahrichi SL; Craig AG; Vale W; Rivier J
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10575-9. PubMed ID: 7479843
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
Dautzenberg FM; Wille S; Lohmann R; Spiess J
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
[TBL] [Abstract][Full Text] [Related]
14. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
[TBL] [Abstract][Full Text] [Related]
16. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
[TBL] [Abstract][Full Text] [Related]
17. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
[TBL] [Abstract][Full Text] [Related]
18. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.
Higelin J; Py-Lang G; Paternoster C; Ellis GJ; Patel A; Dautzenberg FM
Neuropharmacology; 2001; 40(1):114-22. PubMed ID: 11077077
[TBL] [Abstract][Full Text] [Related]
19. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
20. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
Dautzenberg FM; Higelin J; Brauns O; Butscha B; Hauger RL
Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
